Regenerative Medicine Offers Life-Changing Diabetes Treatment

Financial Times (, By Clive Cookson, Nov.13, 2014

Regenerative medicine offers life-changing diabetes treatment –

Read entire article.

The Bioartificial Pancreas: Edging Toward Reality

The Medtech Strategist, By Mary Thomson, Nov. 13, 2014

Researchers have engineered novel devices to house and protect insulin-secreting beta cells inside the body, and they are combining that technology with human stem cell-derived or even animal-derived beta cells. Their aim is to construct what is essentially a bioartificial pancreas, supplied with readily available lab-grown cells and designed to restore normal, or near-normal, insulin production and glucose regulation to patients with type 1 diabetes.

Read entire article.

ViaCyte Wins US Patent to Manufacture Human Pancreatic Progenitor Cells, By Zachary Brennan, Nov. 11, 2014

Regenerative medicine company ViaCyte has been granted a US patent for the manufacture of human pancreatic progenitor cells from definitive endoderm cells.

JDRF Walk: Taking Steps to Cure Type 1 Diabetes, By Steve Price, Nov. 8, 2014

Every year, 145 children in San Diego are diagnosed with type 1 juvenile diabetes. This Saturday, the walk sets out to raise money to hopefully one day find a cure, and some of that money is going to a local company that is currently working on a major medical breakthrough.

ViaCyte calls it a functional cure. You’ll still have diabetes, but you won’t have to keep monitoring your insulin levels multiple times a day.

Read entire article.